Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005485 · ClinicalTrials.gov registry record

The Jackson Heart Study of Cardiovascular Disease Among African Americans

A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

Active
Registry status
5,306
Enrollment target
1
Study location

NCT00005485 is a study of Hypertension and Cardiovascular Diseases that is active but no longer recruiting, run by National Heart, Lung, and Blood Institute (NHLBI). The registered enrollment target is 5,306 participants, above the 3,496-participant average among 470 other Hypertension trials with a reported enrollment target (52% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005485, a study of Hypertension and Cardiovascular Diseases, is active but no longer recruiting, sponsored by National Heart, Lung, and Blood Institute (NHLBI).

ACTIVE NOT RECRUITING
Registry status
5,306 participants
Enrollment target
1
Study location

Study Summary

This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American adults. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougaloo College, and the University of Mississippi Medical Center), NIMHD, and NHLBI.

Study Locations (1)

Mississippi

  • UMMC, JSU, Tougaloo College, MSDH - Jackson

Trial Details

FieldValue
Enrollment Target 5,306 participants
Start Date 2000-09-19
Est. Completion 2025-08-12

What the Registry Record Tells You About NCT00005485

The ClinicalTrials.gov registry entry for NCT00005485 describes a study currently listed as active not recruiting, categorized as an unspecified phase. The registered enrollment target is 5,306 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 3,496-participant average among 470 other Hypertension trials with a reported enrollment target (52% higher). The listed sponsor is National Heart, Lung, and Blood Institute (NHLBI), which has 501 total studies on file at ClinicalTrials.gov.

The record links to 6 conditions, with Hypertension appearing as the primary indexed condition, and to 0 interventions.

NCT00005485 reports 1 study location spanning 1 distinct geographic area - top geographies include Mississippi.

Frequently Asked Questions

What is clinical trial NCT00005485 about?

NCT00005485 is a clinical study titled "The Jackson Heart Study of Cardiovascular Disease Among African Americans". This is a prospective study of the environmental and genetic factors that influence the development of cardiovascular disease (CVD) in African American adults. The cohort is a collaboration among multiple institutions (Jackson State University, Mississippi State Department of Health, Tougaloo Colleg...

What is the current status of trial NCT00005485?

This trial is currently active not recruiting. The enrollment target is 5,306 participants. The study started on 2000-09-19. Estimated completion is 2025-08-12.

What conditions does trial NCT00005485 study?

This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Heart Diseases, Atherosclerosis, Coronary Disease.

Who is sponsoring clinical trial NCT00005485?

This trial is sponsored by National Heart, Lung, and Blood Institute (NHLBI), which has 501 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005485 being conducted?

This trial has 1 study location across Mississippi. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hypertension

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.